Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
ENTA
— Enanta Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q2 2024 Earnings Call Summary
MAY 6, 2024
REVENUE
$17.1M
-5.3%
NET MARGIN
-182.7%
+2.9 PTS
EPS
-$1.47
+7.0%
FREE CASH FLOW
-$30.3M
-17.4%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →